Trends in Biotechnology is unique in drawing together a wide readership of scientists and engineers from the many disciplines of the applied biosciences. As in the successful biotechnology companies and leading academic research groups, Trends in Biotechnology reflects the view that biotechnology is the integrated use of many biological technologies - from molecular genetics to biochemical engineering. This integration is essential for the effective translation of novel research into application. The journal addresses what is new, significant and practicable.

Its successful blend of articles has made Trends in Biotechnology one of the most highly regarded and highly cited review journals in the field.

Audience
All biotechnologists who take an integrated, multidisciplinary approach to the applied biosciences. Of particular interest to industrial or academic scientists active in R&D in molecular biotechnology, gene transfer and expression, applied microbiology, environmental biotechnology, biofuels and bioenergy, nanotechnology, bioprocessing, chemical biotechnology, tissue engineering and regenerative medicine, rDNA therapeutics and vaccines, plant biotechnology, patenting and regulatory issues.


Instructions to Authors
Articles for Trends in Biotechnology are usually commissioned by the Editor, but proposals for articles are welcome, especially for the Research Focus section. Prospective authors should send a brief summary, citing key references, to the Editor, who will supply guidelines on manuscript preparation if the proposal is accepted. The submission of completed manuscripts without prior consultation with the Editor is strongly discouraged. Authors should note that all major articles in Trends in Biotechnology are peer-reviewed and publication cannot be guaranteed.

Reviews and Opinion articles form the foundation of each monthly issue. Reviews are invited from leading researchers in a specific field and objectively chronicle recent and important developments. Opinon articles provide a forum for debate and hypothesis. The Research Focus section includes short articles highlighting topical issues and recent research papers of particular note, as well as articles reporting on groundbreaking technical advances.

Trends in Biotechnology welcomes correspondence. The decision to publish rests with the Editor, and the author(s) of any article discussed in a Letter will normally be invited to reply. Letters may address topics raised in recent issues of the journal, or other matters of general interest to plant scientists. Letters should be no more than 700 words long with a maximum of 12 references and one figure. An electronic version of the text should be e-mailed to : ttec@elsevier.com

(or post a hardcopy plus an electronic copy on disc to)
The Editor
Trends in Biotechnology
Elsevier Ltd
32 Jamestown Road
London
UK, NW1 7BY


Advisory Editorial Board
A. Atkinson, Warwick, UK
M.A. Burns, MI, USA
J.Cabral, Lisbon, Portugal
G. Carrea, Milan, Italy
J. Chataway, Milton Keynes, UK
A. Colman, Edinburgh, UK
D. Cowan, London, UK
V. Demidov, Boston, USA
M. Ferrari, Houston, USA
M. Fussenegger, Zurich Switzerland
H. Hoogenboom, Maastricht, The Netherlands
D. Jones, Dunedin, New Zealand
N. Kalogerakis, Crete, Greece
D. Kell, Manchester, UK
R. Langer, Cambridge, USA
J. Li, Beijing, China
L. Macaskie, Birmingham, UK
B. Mattiasson, Lund, Sweden
A. Middelberg, Queensland, Australia
J.D. Murray, Davis, USA
G. Stephanopoulos, Cambridge, USA
A.P.F. Turner, Silsoe, UK
T. Twardowski, Poznan, Poland
M. Uhlén, Stockholm, Sweden
K. Van't Riet, Wageningen, The Netherlands
U. Von Stockar, Lausanne, Switzerland
J. Wells, San Francisco, USA


Abstracting/Indexing
Abstracts in Biocommerce
Bibliography of Agriculture (AGRICOLA)
Biotechnology Citation Index
CAB Abstracts International
Chemical Abstracts
Current Contents (Life Science)
Index Veterinarius
Medline/MEDLARS Online
Reference Update
Science Citation Index
SciSearch/Science Citation Index Expanded


Bibliographic Information
Commenced publication 1983
Volume 26
2008, 12 issues
ISSN: 0167-7799

Statement on publishing ethics
The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct.

Conflict of Interest Policy
The Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author’s work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict. For more information, please refer to: http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest

Copyright statement
© 2008 Elsevier Ltd. All rights reserved.
This journal and the individual contributions contained in it are protected under copyright by Elsevier Ltd, and the following terms and conditions apply to their use:


Photocopying
Single photocopies of single articles may be made for personal use as allowed by national copyright laws. Permission of the publisher and payment of a fee is required for all other photocopying, including multiple or systematic copying, copying for advertising or promotional purposes, resale, and all forms of document delivery. Special rates are available for educational institutions that wish to make photocopies for non-profit educational classroom use.
Elsevier Science Rights & Permissions Department
PO Box 800
Oxford
UK OX5 1DX
Tel:+44 (0) 1865 843830
Fax: +44 (0) 1865 853333
E-mail: permissions@elsevier.co.uk

You may also contact Global Rights directly through Elsevier's home page (http://www.elsevier.com), selecting first 'Customer Support', then 'Permissions', then 'Permissions Request Form'.

In the USA, users may clear permissions and make payments through the

Copyright Clearance Center Inc
222 Rosewood Drive
Danvers
MA 01923, USA
Tel: +1 (978) 750 8400
Fax: +1 (978) 750 4744

and in the UK through the

Copyright Licensing Agency Rapid Clearance Service (CLARCS)
90 Tottenham Court Road
London, UK W1P 0LP
Tel: +44 (0) 20 7631 5555
Fax: +44 (0) 20 7436 5500

Other countries may have a local reprographic rights agency for payments.

Derivative Works
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution.
Permission of the publisher is required for all other derivative works, including compilations and translations.


Electronic Storage or Usage
Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated.
Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher.
Address permissions requests to: Elsevier Science Rights & Permissions Department, at the mail, fax and e-mail addresses noted above.


Notice
No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made.
Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.